(Q46823146)
Statements
Are delayed-start design trials to show neuroprotection in Parkinson's disease fundamentally flawed? (English)
Carl E Clarke
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference